Skip to main content

BCDG Information & Policies

A reference for active Blood Cancer Discoveries Grant (BCDG) grantees

For information about other programs, and about applying for LLS research funding, click here.

Grant Requirements

Reporting Schedule: Progress, IP Disclosure, and Financial Reports are required for each year of the grant, and Publications Reports are required each quarter. Below is an example of a typical schedule for a new BCDG grant starting on July 1, 2020.

Example Reporting Schedule for New BCDG Grant 2020*

Publications Report #1

October 1, 2020

Publications Report #2

  January 1, 2021

Interim Year 1 Progress Report
Interim Year 1 IP Disclosure Report
Interim Year 1 Financial Report

  Sept 1, 2021

Publications Report #3

  July 1, 2021

Publications Report #4

  October 1, 2021

Publications Report #5

  January 1, 2022

Publications Report #6

  April 1, 2022

Interim Year 2 Progress Report
Interim Year 2 IP Disclosure Report
Interim Year 2 Financial Report

  Sept 1, 2022

Publications Report #8

  July 1, 2022

Publications Report #9

  October 1, 2022

Publications Report #10

  January 1, 2023

Publications Report #11

  April 1, 2023

Final Progress Report
Final IP Disclosure Report
Final Financial Report

Sept 1, 2023


*Note: Because of the COVID-19 health emergency, the 2020 activation of BCDG projects was moved from April 1 to July 1. The Grant Agreements for these projects reflect the reporting schedule that was originally planned with the April 1 activation date. The updated reporting schedule is shown above and available under "Reports Due" in the LLS Research Portal at

The reporting schedule may also be altered upon the approval of a leave of absence or no-cost extension request. Always defer to the schedule available under "Reports Due" in the LLS Research Portal at; this is kept updated with the dates specific to each project.


Report Submission: LLS research grant reporting is conducted through the LLS Research Portal (FLUXX). Access this portal using the same username and password that were used during the application process.
Individuals responsible for submitting reports must be manually added to each grant in our system in order for them to have reporting access. Contact to update reporting access for your grant.

Progress Reports and Publications Reports should be submitted by the researcher (the PI). Financial Reports should be submitted by the financial officer, and IP Disclosure Reports should be submitted by the technology/transfer officer.

Researchers and administrators should be careful to follow all instructions on the report web form and downloadable template. Reports that fail to follow instructions will be returned for revision, which may delay grant payment. Do not save templates for future use the templates are subject to change and therefore must be newly downloaded for each submission.

Download the Report Submission Guide for detailed instructions on submitting a report in the LLS Research Portal (FLUXX).
Note: FLUXX recently updated the grantee portal view, so the pages will visually be different from the screenshots shown in this guide. This change is aesthetic only; the process for submitting reports remains unchanged.


Grant Payment

LLS pays research grants quarterly in March, June, September, and December. Payments are contingent upon reporting requirements; all report approvals must be up to date in order for payment to be processed. A list of sent payments can be viewed in the LLS Research Portal (FLUXX) under Dispersed Payments.



LLS approval is required at least 30 days prior to an award's transfer to a new institution or laboratory. In order to submit a request for transfer, complete a Special Requests report in the LLS Research Portal (FLUXX). Your request will be reviewed, and you will receive a notification from LLS with the results of the review or with a request for more information. Approval is contingent upon continued research support and sponsorship, fitness of the new research environment, and circumstances of your award type and timing of the request (see your Grant Agreement for more details).

Transfer to another investigator may be allowed if the original grantee is unable to continue the project (e.g. if they move to a new institution unequipped for the project). Contact to inquire about a grantee transfer.


Leaves of Absence

LLS approval is required at least 30 days prior to the interruption of an award. Leaves of absence may not exceed 1 year in duration. In order to submit a request for leave of absence, complete a Special Requests report in the LLS Research Portal (FLUXX). If the request is approved, funding of the award will be suspended during the leave period, and the grant term will be extended for a period equal to the duration of the suspension (e.g. following an approved 1-year leave of absence, an award originally scheduled to end 6/30/2022 will end 6/30/2023).


No-Cost Extensions

Grantees are permitted to request a no-cost extension for a maximum of one year in duration. At the end of the no-cost extension period, any funds remaining must be returned to LLS. To request a no-cost extension, complete a Special Requests report in the LLS Research Portal (FLUXX). If the request is approved, the grant period will be extended for the amount of time requested, and final reports will be due 60 days following the new end date. The final payment will be paid once final reports are received and approved by LLS.

If you have questions regarding your grant that are not addressed here, please contact the Research Administration Team at